FDA Misses Deadline to File Financials for Review
Jan 24th, 2012 | By Jane AkreThe U.S. Food and Drug Administration (FDA) was supposed to submit a new agreement to lawmakers on January 15, concerning how much funding it will need next year to review medical devices and conduct product reviews. Bloomberg reports (here) no new agreement was filed – the FDA essentially missed its deadline. That may hurt the
[continue reading...]



